spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  PASCAL 

 HSMN NewsFeed - 3 Jul 2025
Novartis Provides Update on Phase III GCAptAIN Study of Cosentyx(R) in Giant Cell Arteritis (GCA)
Biopharmaceuticals
 HSMN NewsFeed - 8 Dec 2022
Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 10 Jul 2020
World's First FDA IDE Coronary Patient Treated With a DEB
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2020
Edwards PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 Dec 2019
European Commission Approves EVENITY(R) (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Oct 2019
European Symposium to Advance Adoption of MRI-Guided Radiation Therapy
Devices Radiology Oncology
 HSMN NewsFeed - 18 Oct 2019
EVENITY(R) (Romosozumab) Receives Positive CHMP Opinion For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Jun 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 May 2019
Edwards Announces Milestones For Transcatheter Mitral Program
Devices Cardiology Interventional
 HSMN NewsFeed - 23 Apr 2019
Epic Sciences Receives CE Mark for Liquid Biopsy Test Collection Kit
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 8 Jan 2019
EVENITY(TM) (romosozumab) Receives Approval In Japan For The Treatment Of Osteoporosis In Patients At High Risk Of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Nov 2018
Sobi(TM) to Acquire Synagis(R) US Rights From AstraZeneca - Creates a Platform for Global Growth
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 13 Jul 2018
Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY(TM) (romosozumab) To The US FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jul 2017
Amgen And UCB Provide Update On Regulatory Status Of EVENITY(TM) (romosozumab) In The US
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2016
PharmaMar Appoints Pascal Besman as Chief Operating Officer of PharmaMar U.S.
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Jul 2016
Amgen and UCB Submit Biologics License Application for Romosozumab to the FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Sep 2015
Valeant And AstraZeneca To Partner On Brodalumab
Biopharmaceuticals Dermatology Licensing Distribution
 HSMN NewsFeed - 10 Oct 2014
Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2014
CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI(R)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 3 Sep 2014
MRI Interventions Welcomes Pascal E.R. Girin to Board of Directors
Devices Radiology Surgery Personnel
 HSMN NewsFeed - 28 Aug 2014
Armetheon Completes $7.0 Million Series A Financing
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 8 Apr 2014
Epic Sciences Appoints Pascal Bamford, Ph.D. as Vice President of Product Development
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 22 Jul 2013
SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 15 Feb 2013
BIOTRONIK Ilesto 7 ICD/CRT-D Series With ProMRI(R) Technology Gains CE Approval
Devices Cardiology Regulatory
 HSMN NewsFeed - 12 Sep 2012
New Knee Implant Is Changing The Way Patients And Surgeons View Revision Hinged Knee Replacement
Devices Orthopaedic
 HSMN NewsFeed - 24 Apr 2012
Halscion Announces European CE Mark Approval of Celotres(TM) for Wound Healing and Scar Symptoms
Devices Wound Care Regulatory
 HSMN NewsFeed - 7 Sep 2011
OptiMedica Receives CE Mark for Catalys(TM) Precision Laser System
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 24 Mar 2011
Bausch & Lomb Appoints David Mordaunt, Ph.D. as Vice President, Development and Research, Surgical
Devices Ophthalmology Personnel
 HSMN NewsFeed - 14 Jan 2011
GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease
Biopharmaceuticals Devices Radiology Neurology
 HSMN NewsFeed - 7 May 2010
Recordati Signs an Agreement With Zambon for the Co-Marketing of Silodosin in France
Biopharmaceuticals Urology Licensing
 HSMN NewsFeed - 23 Sep 2009
EDAP Enhances Ablatherm-HIFU European Marketing Strategy
Devices Oncology
 HSMN NewsFeed - 19 Feb 2009
European Commisssion Grants Ferring Pharmaceuticals Approval of FIRMAGON(R) (Degarelix) for Treatment of Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Jan 2009
Optimedica Taps Stephen P. Hanlon As New Vice President Of Research And Development
Devices Ophthalmology Personnel
 HSMN NewsFeed - 24 Nov 2008
Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Biopharmaceuticals
 HSMN NewsFeed - 13 Oct 2008
Radi Medical Systems AB and GE Healthcare Announce Cooperation to Integrate FFR and PressureWire(R) Aeris in GE Mac-Lab(R) IT
Devices Cardiology Monitoring
 HSMN NewsFeed - 21 Jul 2008
ev3 Inc. Announces Promotion of Pascal E.R. Girin to Lead Global Neurovascular Business and International
Devices Personnel
 HSMN NewsFeed - 13 Jun 2008
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
Biopharmaceuticals
 HSMN NewsFeed - 16 Apr 2008
OptiMedica Names Topcon Medical Japan as Exclusive Distribution Partner
Devices Ophthalmology Distribution
 HSMN NewsFeed - 3 Apr 2008
Masimo PVI(TM) Cleared for Market in Japan
Devices Monitoring Regulatory
 HSMN NewsFeed - 3 Apr 2008
OptiMedica Names New Vice Presidents of Marketing and Operations
Devices Ophthalmology Personnel
 HSMN NewsFeed - 26 Mar 2008
OptiMedica Secures $16 Million in Series C Funding
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 12 Jul 2007
OptiMedica(R) and Topcon Europe Medical(R) Sign Distribution Agreement
Devices Ophthalmology Distribution
 HSMN NewsFeed - 2 Jul 2007
NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jun 2007
Masimo Announces Continuous Noninvasive Functional Hemodynamic Monitoring With Plethysmograph Variability Index (PVI), Latest Masimo Rainbow SET Measurement
Devices Monitoring
 HSMN NewsFeed - 12 Jun 2007
Mark J. Forchette Named President and Chief Executive Officer of OptiMedica(R)
Devices Ophthalmology Personnel
 HSMN NewsFeed - 26 Mar 2007
HCA and University of Miami Announce Signing of Letter of Intent to Pursue the Sale of HCA's Cedars Medical Center to UM
Hospitals & Healthcare Systems
 HSMN NewsFeed - 11 Nov 2006
OptiMedica Launches Suite of Integrated Practice Solutions for the Pascal Photocoagulator
Devices Ophthalmology
 HSMN NewsFeed - 25 Sep 2006
OptiMedica Announces Clinical Outcomes of 1,200 Patients Treated with PASCAL Method of Photocoagulation
Devices Ophthalmology
 HSMN NewsFeed - 9 Sep 2006
OptiMedica Receives ISO Certification and CE Mark for the PASCAL(R) Photocoagulator
Devices Ophthalmology Regulatory
Return to NewsFeed  

 Additional items found! 10

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 10 additional stories matching:
PASCAL
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.